Arialief is rooted in the science of nerve support and healing. It targets nerve discomfort by focusing on neural health and ...

Green tea extract, lemon water, ginger tea, apple cider vinegar (ACV) water, or herbal teas like chamomile and hibiscus can ...

Meet the Coastland Dental team, where advanced technology meets compassionate care in the heart of Burbank. “We are always ...

EnGeneIC Pty Ltd, a Sydney-based biotechnology company and leader in innovative cancer therapies, has announced the successful dosing of the first patient in its open-label, multicentre, Phase I/IIa ...

One such product gaining attention in 2025 is Herpesyl, a nutritional supplement that claims to not just suppress herpes ...

Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, ...

H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City. Management will be holding one-on-one meetings with investors.

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court of Appeals for the Federal Circuit affirmed-in-part and vacated-in-part the Patent Trial ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...

Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by ...

R&D Expense: Research and development expenses for the first quarter of 2025 were $52.2 million, as compared to $45.8 million for the same period in 2024. This increase was primarily due to the final ...

IBA (Ion Beam Applications), the world leader in particle accelerator technology, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency ...